{"title":"“紫锥菊素衍生物酪氨酸- dna磷酸二酯酶1抑制剂的发现、结构修饰和构效关系研究及其潜在的抗肿瘤活性”的勘误表[欧洲]。医学化学。298 (2025)118040]","authors":"Chuan-Sheng Yao, Jiaqi Zhu, Xiang Gao, Ao Chen, Yue-Wen Li, Wen-Ya Liu, Li-Shuang Guo, Yong-Chun Wu, Cui-Xian Zhang, Xi-Xin He, Lin-Kun An","doi":"10.1016/j.ejmech.2025.118101","DOIUrl":null,"url":null,"abstract":"The authors regret that the publication shows that some compounds’ structures are incorrect because of text editing reason in <strong>Tables 1–3</strong>, including compounds <strong>9–16</strong> in <strong>Table 1</strong>, compounds <strong>17–18</strong>, <strong>29–33</strong>, <strong>35–54</strong>, <strong>56–59</strong> in <strong>Table 2</strong>, and compounds <strong>62–67</strong> in <strong>Table 3</strong>. Corrected <strong>Tables 1–3</strong> are shown below.","PeriodicalId":314,"journal":{"name":"European Journal of Medicinal Chemistry","volume":"120 1","pages":""},"PeriodicalIF":5.9000,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Corrigendum to “Discovery, structural modification and structure-activity relationship study of Echinulin derivatives as tyrosyl-DNA phosphodiesterase 1 inhibitors and their potential antitumor activity” [Eur. J. Med. Chem. 298 (2025) 118040]\",\"authors\":\"Chuan-Sheng Yao, Jiaqi Zhu, Xiang Gao, Ao Chen, Yue-Wen Li, Wen-Ya Liu, Li-Shuang Guo, Yong-Chun Wu, Cui-Xian Zhang, Xi-Xin He, Lin-Kun An\",\"doi\":\"10.1016/j.ejmech.2025.118101\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The authors regret that the publication shows that some compounds’ structures are incorrect because of text editing reason in <strong>Tables 1–3</strong>, including compounds <strong>9–16</strong> in <strong>Table 1</strong>, compounds <strong>17–18</strong>, <strong>29–33</strong>, <strong>35–54</strong>, <strong>56–59</strong> in <strong>Table 2</strong>, and compounds <strong>62–67</strong> in <strong>Table 3</strong>. Corrected <strong>Tables 1–3</strong> are shown below.\",\"PeriodicalId\":314,\"journal\":{\"name\":\"European Journal of Medicinal Chemistry\",\"volume\":\"120 1\",\"pages\":\"\"},\"PeriodicalIF\":5.9000,\"publicationDate\":\"2025-09-19\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Journal of Medicinal Chemistry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ejmech.2025.118101\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Medicinal Chemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ejmech.2025.118101","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
Corrigendum to “Discovery, structural modification and structure-activity relationship study of Echinulin derivatives as tyrosyl-DNA phosphodiesterase 1 inhibitors and their potential antitumor activity” [Eur. J. Med. Chem. 298 (2025) 118040]
The authors regret that the publication shows that some compounds’ structures are incorrect because of text editing reason in Tables 1–3, including compounds 9–16 in Table 1, compounds 17–18, 29–33, 35–54, 56–59 in Table 2, and compounds 62–67 in Table 3. Corrected Tables 1–3 are shown below.
期刊介绍:
The European Journal of Medicinal Chemistry is a global journal that publishes studies on all aspects of medicinal chemistry. It provides a medium for publication of original papers and also welcomes critical review papers.
A typical paper would report on the organic synthesis, characterization and pharmacological evaluation of compounds. Other topics of interest are drug design, QSAR, molecular modeling, drug-receptor interactions, molecular aspects of drug metabolism, prodrug synthesis and drug targeting. The journal expects manuscripts to present the rational for a study, provide insight into the design of compounds or understanding of mechanism, or clarify the targets.